27 results
6-K
EX-99.1
BPTS
Biophytis
22 Feb 24
Publication of a book on the medicine and science of longevity
2:41pm
opportunity for the Company.
Far from the transhumanist myth of eliminating aging and death, the aim of this book is to mobilise society so that elderly
6-K
EX-99.1
BPTS
Biophytis
27 Sep 23
Half-year Financial Report
5:00pm
, adverse events (25% vs. 31%).Detailed results of the study were presented at the European Respiratory Society Lung Science Conference in March 2023 … in Estoril, Portugal and at the American Thoracic Society International Conference in Washington DC, United States in May 2023.
Based on the results
6-K
EX-99.1
BPTS
Biophytis
11 Sep 23
Biophytis obtains FDA Authorization to initiate the SARA-31 phase 3 study in sarcopenia
9:52am
for effective therapeutics against a major disease in an aging society. We can count on the growing interest of the medical community in Europe and the United
6-K
EX-99.1
BPTS
Biophytis
20 Jun 23
Biophytis reports clinical results for Sarconeos (BIO101) in sarcopenia treatment at the 16th SCWD International Congress
6:10am
in the 16th SCWD (Society on Sarcopenia, Cachexia & Wasting disorders) international congress, a flagship event bringing together experts from all over
6-K
a7c2g4 dmlcf
25 May 23
Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
11:00am
6-K
EX-99.1
1t4ouyzsldkff8i
25 May 23
Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
11:00am
6-K
EX-99.1
nxsdpi
28 Jun 22
Current report (foreign)
10:32am
20-F/A
d0wit
28 Oct 21
Annual report (foreign) (amended)
5:16pm
20-F
wnfw2k8 2pbzl
12 Mar 21
Annual report (foreign)
2:38pm
424B4
vsy7whcb8ravt3opc
11 Feb 21
Prospectus supplement with pricing info
12:00am
FWP
smpoh47
8 Feb 21
Free writing prospectus
4:33pm
F-1/A
j216kp778kh
4 Feb 21
Registration statement (foreign) (amended)
2:42pm
F-1/A
5atcrmoy5otg82ab
2 Feb 21
Registration statement (foreign) (amended)
5:27pm
F-1/A
EX-4.1
h9dn1owf
2 Feb 21
Registration statement (foreign) (amended)
5:27pm
F-1
8epj58i
19 Jan 21
Registration statement (foreign)
5:05pm
DRS/A
wc3hihvd
23 Dec 20
Draft registration statement (amended)
12:00am
DRS
yl9ttuzj55
20 Nov 20
Draft registration statement
12:00am